Assessing chest radiographic quality and the influence of COVID-19 pathology: the Australian experience

评估胸部X光片质量及COVID-19病理的影响:澳大利亚的经验

阅读:1

Abstract

INTRODUCTION: Quality assurance (QA) in medical imaging ensures consistently high-quality images at acceptable radiation doses. However, the applicability of the chest X-ray (CXR) QA tool in images with pathology, particularly infectious diseases like COVID-19, has not been explored. This study examines the utility of the European Guidelines for image quality in QA of CXRs with varying severity and types of infectious disease. METHODS: A convenient sampling methodology was employed to recruit 25 participants (qualified radiographers: n = 13 and 4th-year undergraduate radiography students: n = 12) to evaluate 70 CXR images using the European Guidelines for image quality in CXRs. The image dataset comprised of COVID-19 and non-COVID-19 cases, which were randomly selected to reflect routine clinical practice variability. Participants independently rated image quality based on 10 criteria in the European guidelines on quality criteria for CXRs using a six-point Likert scale. Image quality ratings of normal and pathological CXR images were compared using a Kruskal-Wallis test. Spearman's ranked order correlation was used to assess the association between quality criteria ratings. RESULTS: CXRs with no pathology or non-COVID pathologies exhibited statistically higher total QA scores compared to CXRs with COVID-19 and indeterminate COVID-19 (P < 0.001). This trend was evident across various QA factors, especially those associated with patient inspiration. Higher levels of infection corresponded to lower QA ratings. No differences were found between different pathologies regarding the medial border of the scapulae being outside the lung fields. CONCLUSIONS: Severe pathology negatively impacts the technical quality of CXRs with COVID-19 features without necessarily affecting their diagnostic value. The findings emphasise the need to prioritise diagnostic ability over technical quality when evaluating CXRs exhibiting diffuse signs of pathology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。